+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Precore mutant hepatitis B virus-associated fulminant hepatitis during infliximab therapy for rheumatoid arthritis



Precore mutant hepatitis B virus-associated fulminant hepatitis during infliximab therapy for rheumatoid arthritis



Clinical Rheumatology 32(Suppl. 1): S47



A 73-year-old female, who suffered from rheumatoid arthritis for 10 years, developed precore mutant hepatitis B virus-associated fulminant hepatitis after 1 year of infliximab therapy and subsequent methotrexate withdrawal. We emphasize the importance of preemptive antiviral therapy before starting infliximab administration and withdrawing immunosuppressive drugs.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036803432

Download citation: RISBibTeXText

PMID: 20379839

DOI: 10.1007/s10067-010-1438-y


Related references

Development of fulminant hepatitis B (precore variant mutant type) after the discontinuation of low-dose methotrexate therapy in a rheumatoid arthritis patient. Arthritis and Rheumatism 44(2): 339-342, 2001

Fulminant hepatitis in an asymptomatic chronic carrier of hepatitis B virus mutant after withdrawal of low-dose methotrexate therapy for rheumatoid arthritis. Clinical and Experimental Rheumatology 22(3): 375-376, 2004

Can hepatitis B virus precore mutant be a cause of fulminant hepatitis? Quantitative analysis of mutant and wild types. Hepatology 22(4 Part 2): 500A, 1995

Genetic mutations of precore region of hepatitis B virus in hepatitis B e antigen-negative patients with fulminant hepatitis B and translation of precore variants in vitro. Zhonghua Gan Zang Bing Za Zhi 9(1): 42-44, 2001

Precore mutant of hepatitis B virus in childhood fulminant hepatitis B: an infrequent association. Journal of Infectious Diseases 171(4): 776-781, 1995

The percentage of hepatitis B virus precore A83 mutant and its dynamicchange in fulminant hepatitis B. Zhonghua Gan Zang Bing Za Zhi 8(2): 96-98, 2000

Low rate of hepatitis B virus precore mutant in fulminant hepatitis in France. Hepatology 16(4 Part 2): 65A, 1992

Selection of a precore mutant after vertical transmission of different hepatitis B virus variants is correlated with fulminant hepatitis in infants. Journal of Medical Virology 47(4): 336-341, 1995

Reactivation of a latent precore mutant hepatitis B virus related chronic hepatitis during infliximab treatment for severe spondyloarthropathy. Annals of the Rheumatic Diseases 64(5): 788-789, 2005

Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab. Haematologica 88(6): Ecr22, 2003

Detection of precore-mutant hepatitis B virus genome in patients with acute and fulminant hepatitis using mutation site-specific assay (MSSA). Hepato-Gastroenterology 49(47): 1352-1356, 2002

Detection of precore/core-mutant hepatitis B virus genome in patients with acute or fulminant hepatitis without serological markers for recent HBV infection. Journal Of Hepatology. 18(3): 369-372, 1993

Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group. Hepatology 29(3): 889-896, 1999

Interferon therapy for fulminant hepatitis associated with precore region mutation in hepatitis B virus carrier. American Journal of Gastroenterology 91(8): 1673-1675, 1996

Precore/core promoter mutations and genotypes of hepatitis B virus in chronic hepatitis B patients with fulminant or subfulminant hepatitis. Journal of Medical Virology 72(4): 545-550, 2004